comparemela.com

Latest Breaking News On - Yosef yarden - Page 3 : comparemela.com

Desperate Cancer Cells

Desperate Cancer Cells
miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.

The puzzle of chemotherapy resistance

What is a breakthrough in cancer research? It is a new piece of a puzzle made up of a million pieces. It may, however, be a piece that allows a picture to start emerging – one that lets us see the shape of the next piece needed to fill in more of the puzzle, or start making changes to rearrange the picture from one of cancerous growth to one of normalcy.

The Israelis helping to conquer cancer

The Israelis helping to conquer cancer
israel21c.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from israel21c.org Daily Mail and Mail on Sunday newspapers.

Prof Eli Keshet to be awarded Israel Prize in life sciences

Follow Feb. 25, 2021 Prof. Eli Keshet is to be awarded the Israel Prize in life sciences this year for his contributions to the development of treatments for a wide range of diseases, Education Minister Yoav Gallant announced on Thursday. Keshet, a professor of molecular biology at the Hebrew University of Jerusalem s medical school, was awarded the prestigious prize for his “pioneering contribution” to understanding the mechanism in which conditions of an oxygen shortage prompt the growth of new blood vessels. This process has “far-reaching effects on the development of many diseases such retinal diseases and cancer,” said the prize committee. The prize jury, headed by biochemist Prof. Yosef Yarden of the Weizmann Institute of Science, said Keshet’s discoveries “led to the recognition that an excess of oxygen given in treating premature babies leads to their becoming blind, and has brought about a change in the treatment of premature babies after their birth.”

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.